Table 5.
Women with preeclampsia (%) | Women without preeclampsia (%) | x2 | P | OR | 95% CI | |
---|---|---|---|---|---|---|
NR3C1 | 46.7 | 6.7 | 6.13 | 0.013* | 12.25 | (1.27–118.37) |
CYP11A1 | 56.2 | 40.0 | 0.819 | 0.366 | 1.92 | (0.46–8.05) |
HSD11B2 | 50.0 | 60.0 | 0.313 | 0.576 | 0.66 | (0.16–2.77) |
HSP90AA1 | 64.3 | 15.4 | 6.6 | 0.01* | 9.9 | (1.54–63.69) |
CRHBP | 15.4 | 30.8 | 0.352 | 0.867 | 0.4 | (0.06–2.77) |
The cut point was taken as appointed by the cut off finder (18).
Statistical significance p < 0.05.
Differences between cases and controls.